Anticorps Recombinant de lapin anti-CXCL7/PPBP

CXCL7/PPBP Recombinant Antibody for FC (Intra)

Hôte / Isotype

Lapin / IgG

Réactivité testée

rat

Applications

FC (Intra)

Conjugaison

Non conjugué

CloneNo.

250049B8

N° de cat : 98497-3-RR

Synonymes

Chemokine (C-X-C motif) ligand 7, Cxcl7, Ppbp



Applications testées

Résultats positifs en FC (Intra)Transfected HEK-293T cells,

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98497-3-RR cible CXCL7/PPBP dans les applications de FC (Intra) et montre une réactivité avec des échantillons rat

Réactivité rat
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène CXCL7/PPBP Protéine recombinante Eg3405
Nom complet pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
Masse moléculaire calculée12 kDa
Numéro d’acquisition GenBankNM_153721.1
Symbole du gène Ppbp
Identification du gène (NCBI) 246358
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2 - 8°C. Stable for one year after shipment.

Informations générales

PPBP, slso named as NAP2, or β-Thromboglobulin, is a platelet-derived growth factor that belongs to the CXC chemokine family. This growth factor is a potent chemoattractant and activator of neutrophils. It has been shown to stimulate various cellular processes including DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by synovial cells.

Protocole

Product Specific Protocols
FC protocol for CXCL7/PPBP antibody 98497-3-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}